These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18758210)

  • 21. Multisite evaluation of noninvasive bladder pressure flow recording using the penile cuff device: assessment of test-retest agreement.
    Clarkson B; Robson W; Griffiths C; McArdle F; Drinnan M; Pickard R
    J Urol; 2008 Dec; 180(6):2515-21. PubMed ID: 18930484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of urodynamic analysis in patients with benign prostatic enlargement complicated with diabetes mellitus.
    Zhang K; Xu Z; Zhang J; Wang H; Zhang D; Shi B
    Urol Int; 2008; 81(2):149-52. PubMed ID: 18758211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
    Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
    BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracorporeal magnetic innervation for the treatment of stress urinary incontinence: results of two-year follow-up.
    Hoşcan MB; Dilmen C; Perk H; Soyupek S; Armağan A; Tükel O; Ekinci M
    Urol Int; 2008; 81(2):167-72. PubMed ID: 18758214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Intravesical prostatic protrusion (IPP) and uroflowmetry in the management of benign prostatic enlargement (BPE).
    Foo KT; Lee LS
    Int J Urol; 2010 Jun; 17(6):589. PubMed ID: 20438589
    [No Abstract]   [Full Text] [Related]  

  • 26. Variability and repeatability of perineal sound recording in a population of healthy male volunteers.
    Idzenga T
    Neurourol Urodyn; 2008; 27(8):802-6. PubMed ID: 18551575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A flow rate cut-off value as a criterion for the accurate non-invasive measurement of bladder pressure using a condom-type catheter.
    Pel JJ; van Mastrigt R
    Urol Res; 2003 Jul; 31(3):177-82. PubMed ID: 12748835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.
    Seki N; Yuki K; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interobserver agreement for noninvasive bladder pressure flow recording with penile cuff.
    McArdle F; Clarkson B; Robson W; Griffiths C; Drinnan M; Pickard R
    J Urol; 2009 Nov; 182(5):2397-403. PubMed ID: 19762040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
    Liu HT; Kuo HC
    Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bladder after total urogenital mobilization for congenital adrenal hyperplasia and cloaca--does it behave the same?
    Camanni D; Zaccara A; Capitanucci ML; Mosiello G; Iacobelli BD; De Gennaro M
    J Urol; 2009 Oct; 182(4 Suppl):1892-7. PubMed ID: 19695620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of dutasteride on the efficacy of photoselective vaporization of the prostate: results of a randomized, placebo-controlled, double-blind study (DOP trial).
    Bepple JL; Barone BB; Eure G
    Urology; 2009 Nov; 74(5):1101-4. PubMed ID: 19800668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel natural fill telemetric pressure flow study of discomfort and bladder outlet obstruction.
    Kong HJ; Park S; Lee T; Lee JY; Kim HC; Oh SJ
    J Urol; 2009 Aug; 182(2):601-6. PubMed ID: 19535102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are polymorphisms of the β(3)-adrenoceptor gene associated with an altered bladder function?
    Teitsma CA; de la Rosette JJ; Michel MC
    Neurourol Urodyn; 2013 Mar; 32(3):276-80. PubMed ID: 22972489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Observation on therapeutic effects of elongated needle therapy on dysuria induced by benign prostatic hyperplasia].
    Li J; Han CH; Cheng XH; Zhu GX; Gong XH; Hou WG; Bao YH; Xu YG
    Zhongguo Zhen Jiu; 2008 Oct; 28(10):707-9. PubMed ID: 18972723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures.
    Yap TL; Brown C; Cromwell DA; van der Meulen J; Emberton M
    BJU Int; 2009 Oct; 104(8):1104-8. PubMed ID: 19485993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial comment on: The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement.
    Meuleman EJ
    Eur Urol; 2007 Oct; 52(4):1193-4. PubMed ID: 17293024
    [No Abstract]   [Full Text] [Related]  

  • 39. Air charged and microtip catheters cannot be used interchangeably for urethral pressure measurement: a prospective, single-blind, randomized trial.
    Zehnder P; Roth B; Burkhard FC; Kessler TM
    J Urol; 2008 Sep; 180(3):1013-7. PubMed ID: 18639301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
    Sakr M; Eid A; Shoukry M; Fayed A
    Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.